| Nilotinib effects in Parkinson’s disease and dementia with Lewy bodies F Pagan, M Hebron, EH Valadez, Y Torres-Yaghi, X Huang, RR Mills, ... Journal of Parkinson's disease 6 (3), 503-517, 2016 | 257 | 2016 |
| Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy FL Pagan, JA Butman, JM Dambrosia, M Hallett Neurology 60 (8), 1344-1347, 2003 | 179 | 2003 |
| Nilotinib effects on safety, tolerability, and potential biomarkers in Parkinson disease: a phase 2 randomized clinical trial FL Pagan, ML Hebron, B Wilmarth, Y Torres-Yaghi, A Lawler, EE Mundel, ... JAMA neurology, 2019 | 136 | 2019 |
| Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome A Lerner, A Bagic, EA Boudreau, T Hanakawa, F Pagan, Z Mari, ... Neurology 68 (23), 1979-1987, 2007 | 125 | 2007 |
| Safety of MRI in patients with implanted deep brain stimulation devices M Tagliati, J Jankovic, F Pagan, F Susatia, IU Isaias, MS Okun, ... Neuroimage 47, T53-T57, 2009 | 121 | 2009 |
| Involvement of insula and cingulate cortices in control and suppression of natural urges A Lerner, A Bagic, T Hanakawa, EA Boudreau, F Pagan, Z Mari, ... Cerebral cortex 19 (1), 218-223, 2009 | 121 | 2009 |
| Improving outcomes through early diagnosis of Parkinson's disease. FL Pagan The American journal of managed care 18 (7 Suppl), S176-82, 2012 | 116 | 2012 |
| CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson’s disease M Shimoji, F Pagan, EB Healton, I Mocchetti Neurotoxicity research 16 (3), 318-328, 2009 | 111 | 2009 |
| Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? P Zhai, F Pagan, J Statland, JA Butman, MK Floeter Neurology 60 (8), 1258-1265, 2003 | 102 | 2003 |
| SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea WH Jost, A Friedman, O Michel, C Oehlwein, J Slawek, A Bogucki, ... Neurology 92 (17), e1982-e1991, 2019 | 94 | 2019 |
| Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease FL Pagan, ML Hebron, B Wilmarth, Y Torres‐Yaghi, A Lawler, EE Mundel, ... Pharmacology research & perspectives 7 (2), e00470, 2019 | 87 | 2019 |
| Protection from oxidation enhances the survival of cultured mesencephalic neurons CA Colton, F Pagan, J Snell, JS Colton, A Cummins, DL Gilbert Experimental neurology 132 (1), 54-61, 1995 | 82 | 1995 |
| Rasagiline for mild cognitive impairment in Parkinson's disease: a placebo‐controlled trial D Weintraub, RA Hauser, JJ Elm, F Pagan, MD Davis, A Choudhry, ... Movement Disorders 31 (5), 709-714, 2016 | 69 | 2016 |
| Tyrosine kinase inhibition regulates early systemic immune changes and modulates the neuroimmune response in α-synucleinopathy ML Hebron, I Lonskaya, P Olopade, ST Selby, F Pagan, CEH Moussa Journal of clinical & cellular immunology 5, 259, 2014 | 67 | 2014 |
| Apomorphine subcutaneous injection for the management of morning akinesia in Parkinson's disease S Isaacson, M Lew, W Ondo, J Hubble, T Clinch, F Pagan Movement disorders clinical practice 4 (1), 78-83, 2017 | 66 | 2017 |
| Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial SH Isaacson, W Ondo, CE Jackson, RM Trosch, E Molho, F Pagan, M Lew, ... JAMA neurology, 2020 | 50 | 2020 |
| An update on the use of botulinum toxin therapy in Parkinson’s disease R Mills, L Bahroo, F Pagan Current neurology and neuroscience reports 15 (1), 511, 2015 | 45 | 2015 |
| Targeting neurons in the gastrointestinal tract to treat Parkinson's disease RA Hauser, D Sutherland, JA Madrid, MA Rol, S Frucht, S Isaacson, ... Clinical Parkinsonism & Related Disorders 1, 2-7, 2019 | 37 | 2019 |
| Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks WH Jost, A Friedman, O Michel, C Oehlwein, J Slawek, A Bogucki, ... Parkinsonism & Related Disorders 70, 23-30, 2020 | 34 | 2020 |
| Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy AJ Espay, FL Pagan, BL Walter, JC Morgan, LW Elmer, CH Waters, ... Neurology: Clinical Practice 7 (1), 86-93, 2017 | 29 | 2017 |
